$ News

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

Merck concludes SpringWorks acquisition for $3.4bn

Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

SpringWorks Therapeutics Nears EU Approval for First Desmoid Tumor Therapy, Nirogacestat

SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

Germany’s Merck Set to Buy SpringWorks in $3.9 Billion Deal

Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

Germany’s Merck Nears Roughly $3.5 Billion Deal for SpringWorks

Here's Why We're Not At All Concerned With SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz

Investors push SpringWorks Therapeutics (NASDAQ:SWTX) 4.9% lower this week, company's increasing losses might be to blame

Is SpringWorks Therapeutics, Inc. (SWTX) The Best Immunology Stock To Buy Now?

SpringWorks Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates

SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Team Up to Encourage People with Desmoid Tumors to Take Action Before Their Tumor Takes Over

Wedbush ups SpringWorks target to $81, expects Merck KGaA ‘official’ offer soon

SpringWorks sets wholesale acquisition cost for Gomekli at $206.25 per mg

SpringWorks Therapeutics sets wholesale acquisition cost for GOMEKLI at $206.25